Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin R Sprick

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Cell Death Discovery|February 10, 2017
Martin Leverkus, 1965-2016Henning Walczak, Martin R Sprick
Biochimica Et Biophysica Acta|March 5, 2004
The interplay between the Bcl-2 family and death receptor-mediated apoptosisMartin R Sprick, Henning Walczak
Cancer Letters|April 30, 2013
Label retaining cells in cancer--the dormant root of evil?Anja Schillert, Andreas Trumpp, Martin R Sprick
Oncoscience|February 26, 2019
Still a hopeless case for personalized oncology? Pancreatic cancer revisitedWilko Weichert, Martin R Sprick, Jens T Siveke
EMBO Molecular Medicine|March 29, 2021
Therapy resistance on the RADar in ovarian cancerJonas Schwickert, Franziska M Zickgraf, Martin R Sprick
Cell Cycle (Georgetown, Tex.)|February 18, 2009
One renegade cancer stem cell?Tijana Borovski, Louis Vermeulen, Martin R Sprick, et al.
Pharmaceuticals (Basel, Switzerland)|December 31, 2025
Validation of a UPLC-MS/MS Method for Quantifying Intracellular Olaparib Levels in Resistant Ovarian Cancer CellsSzymon W Kmiecik, Jennifer Lewis, Jonas Schwickert, et al.
Journal of Cellular and Molecular Medicine|February 6, 2016
Protein profile of basal prostate epithelial progenitor cells--stage-specific embryonal antigen 4 expressing cells have enhanced regenerative potential in vivoThomas Höfner, Corinna Klein, Christian Eisen, et al.
The EMBO Journal|August 29, 2002
Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8Martin R Sprick, Eva Rieser, Heiko Stahl, et al.
The Journal of Investigative Dermatology|July 4, 2003
TRAIL-induced apoptosis and gene induction in HaCaT keratinocytes: differential contribution of TRAIL receptors 1 and 2Martin Leverkus, Martin R Sprick, Tina Wachter, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Cell Death Discovery|February 10, 2017
Martin Leverkus, 1965-2016Henning Walczak, Martin R Sprick
Biochimica Et Biophysica Acta|March 5, 2004
The interplay between the Bcl-2 family and death receptor-mediated apoptosisMartin R Sprick, Henning Walczak
Cancer Letters|April 30, 2013
Label retaining cells in cancer--the dormant root of evil?Anja Schillert, Andreas Trumpp, Martin R Sprick
Oncoscience|February 26, 2019
Still a hopeless case for personalized oncology? Pancreatic cancer revisitedWilko Weichert, Martin R Sprick, Jens T Siveke
EMBO Molecular Medicine|March 29, 2021
Therapy resistance on the RADar in ovarian cancerJonas Schwickert, Franziska M Zickgraf, Martin R Sprick
Cell Cycle (Georgetown, Tex.)|February 18, 2009
One renegade cancer stem cell?Tijana Borovski, Louis Vermeulen, Martin R Sprick, et al.
Pharmaceuticals (Basel, Switzerland)|December 31, 2025
Validation of a UPLC-MS/MS Method for Quantifying Intracellular Olaparib Levels in Resistant Ovarian Cancer CellsSzymon W Kmiecik, Jennifer Lewis, Jonas Schwickert, et al.
Journal of Cellular and Molecular Medicine|February 6, 2016
Protein profile of basal prostate epithelial progenitor cells--stage-specific embryonal antigen 4 expressing cells have enhanced regenerative potential in vivoThomas Höfner, Corinna Klein, Christian Eisen, et al.
The EMBO Journal|August 29, 2002
Caspase-10 is recruited to and activated at the native TRAIL and CD95 death-inducing signalling complexes in a FADD-dependent manner but can not functionally substitute caspase-8Martin R Sprick, Eva Rieser, Heiko Stahl, et al.
The Journal of Investigative Dermatology|July 4, 2003
TRAIL-induced apoptosis and gene induction in HaCaT keratinocytes: differential contribution of TRAIL receptors 1 and 2Martin Leverkus, Martin R Sprick, Tina Wachter, et al.
Pageof 5